Perla Yolanda López Camacho

Dr. Perla Yolanda López Camacho


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2022 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LZLizeth M. Zavala-Ocampo
Lizeth M. Zavala-Ocampo
EHEva Aguirre Hernández
Eva Aguirre Hernández
PCPerla Yolanda López Camacho
Perla Yolanda López Camacho
RCRené Cárdenas-Vázquez
René Cárdenas-Vázquez
ADAlejandro Dorazco-González
Alejandro Dorazco-González
GBGustavo Basurto-Islas
Gustavo Basurto-Islas

30 January 2025 in Archiv der Pharmazie
Verified
Journal Article
Open access
GBGustavo Basurto-Islas
Gustavo Basurto-Islas
MDMaximiliano Caye Diaz
Maximiliano Caye Diaz
LOLizeth M. Zavala Ocampo
Lizeth M. Zavala Ocampo
MMMelchor Martínez‐Herrera
Melchor Martínez‐Herrera
PCPerla Yolanda López Camacho
Perla Yolanda López Camacho
Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline and memory impairments and is considered the most prevalent form of dementia. Among the contributing factors to AD lies the hyperphosphorylation of the microtubule‐associated protein tau. Phosphorylated tau reduces its affinity for microtubules and triggers other posttranslational modifications that result in its aggregation and assembly into filaments. These structures progressively accumulate within neurons leading to neurodegeneration. While current AD medications often involve undesirable side effects, the exploration of natural products as a potential therapeutic alternative has gained considerable attention. Numerous compounds have shown potential capacity for reducing tau pathology through different mechanisms, such as inhibiting kinases to reduce tau hyperphosphorylation, enhancing phosphatase activity, and blocking fibril formation. Since tau hyperphosphorylation‐induced aggregation is pivotal in AD onset, this review aims to elucidate the potential of natural products in modulating this crucial molecular mechanism.

17 July 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
LZLizeth M. Zavala-Ocampo
Lizeth M. Zavala-Ocampo
PCPerla Yolanda López Camacho
Perla Yolanda López Camacho
EHEva Aguirre Hernández
Eva Aguirre Hernández
RCRené Cárdenas-Vázquez
René Cárdenas-Vázquez
HBHerlinda Bonilla-Jaime
Herlinda Bonilla-Jaime
GBGustavo Basurto-Islas
Gustavo Basurto-Islas

12 October 2020 in Electromagnetic Biology and Medicine
Verified
Journal Article
Closed access
AMAlejandro Maldonado-Moreles
Alejandro Maldonado-Moreles
TFTeodoro CORDOVA - FRAGA
Teodoro CORDOVA - FRAGA
HBHerlinda Bonilla-Jaime
Herlinda Bonilla-Jaime
PCPerla Yolanda López Camacho
Perla Yolanda López Camacho
GBGustavo Basurto-Islas
Gustavo Basurto-Islas
Plaques formed by abnormal accumulation of amyloid β-peptide (Aβ) lead to onset of Alzheimer’s disease (AD). Pharmacological treatments do not reduce Aβ aggregation neither restore learning and memory. Noninvasive techniques have emerged as an alternative to treat AD, such as stimulation with electromagnetic fields (EMF) that decrease Aβ deposition and reverses cognitive impairment in AD mice, even though some studies showed side effects on parallel magnetic fields stimulation. As a new approach of magnetic field (MF) stimulation, vortex magnetic fields (VMF) have been tested inducing a random movement of charged biomolecules in cells, promoting cell viability and apparently safer than parallel magnetic fields. In this study we demonstrate the effect of VMF on Aβ aggregation. The experimental strategy includes, i) design and construction of a coil capable to induce VMF, ii) evaluation of VMF stimulation on Aβ peptide induced-fibrils-formation, iii) evaluation of VMF stimulation on SH-SY5Y neuroblastoma cell line in the presence of Aβ peptide. We demonstrated for the first time that Aβ aggregation exposed to VMF during 24 h decreased ~ 86% of Aβ fibril formation compared to control. Likewise, VMF stimulation reduced Aβ fibrils-cytotoxicity and increase SH-SY5Y cell viability. These data establish the basis for future investigation that involve VMF as inhibitor of Aβ-pathology and indicate the therapeutic potential of VMF for AD treatment.

23 March 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
PCPerla Yolanda López Camacho
Perla Yolanda López Camacho
Juan Carlos Martínez EspinosaJuan Carlos Martínez Espinosa
Juan Carlos Martínez Espinosa
GBGustavo Basurto-Islas
Gustavo Basurto-Islas
ATAndrea Torres-Zarraga
Andrea Torres-Zarraga
José Martín Márquez-VillaJosé Martín Márquez-Villa
José Martín Márquez-Villa
JMJOAQUIN GONZÁLEZ MARRERO
JOAQUIN GONZÁLEZ MARRERO
Spondias mombin L. has been used in traditional medicine to treat some cases such as infections and inflammations. Some researchers have reported that its biological components, such as carotenoids, carotenes, and phenols, have been characterized primarily by HPLC analysis. Here, we report on the characterization of Spondias mombin L. seed oil by Raman spectroscopy, and the profile identification of fatty acids by 1H-NMR and 13C-NMR spectroscopy. The oil was extracted from different weight volumes of seeds using organic solvent, and each batch was characterized. The analysis of the fatty acid profile by NMR indicated that the seed oil is highly unsaturated (monounsaturated: 29.4% and polyunsaturated: 43.5%). Molecular Raman vibrations at 1006, 1158 and 1523 cm−1 showed the presence of carotenoids, which in turn performed an antioxidant activity. This was demonstrated by a 2,2′-Azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) method. The cell viability in colon cancer cells was promoted in the presence of the oil. The compounds identified in this study from seed oil could be an interesting proposal for food or pharmaceutical applications.

10 May 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
JAJhony Anacleto-Santos
Jhony Anacleto-Santos
Fernando CalzadaFernando Calzada
Fernando Calzada
PCPerla Yolanda López Camacho
Perla Yolanda López Camacho
TLTeresa de Jesús López-Pérez
Teresa de Jesús López-Pérez
ERElba Carrasco Ramírez
Elba Carrasco Ramírez
NRNorma Rivera
Norma Rivera
Pleopeltis crassinervata (Pc) is a fern that, according to ethnobotanical records, is used in Mexican traditional medicine to treat gastrointestinal ailments. Recent reports indicate that the hexane fraction (Hf) obtained from Pc methanolic frond extract affects Toxoplasma gondii tachyzoite viability in vitro; therefore, in the present study, the activity of different Pc hexane subfractions (Hsf) obtained by chromatographic methods was evaluated in the same biological model. Gas chromatography/mass spectrometry (GC/MS) analysis was carried out for hexane subfraction number one (Hsf1), as it showed the highest anti-Toxoplasma activity with a half-maximal inhibitory concentration (IC50) of 23.6 µg/mL, a 50% cytotoxic concentration (CC50) of 398.7 µg/mL in Vero cells, and a selective index (SI) of 16.89. Eighteen compounds were identified by Hsf1 GC/MS analysis, with the majority being fatty acids and terpenes. Hexadecanoic acid, methyl ester was the most commonly found compound (18.05%) followed by olean-13(18)-ene, 2,2,4a,8a,9,12b,14a-octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,12,12a,12b,13,14,14a,14b-eicosahydropicene, and 8-octadecenoid acid, methyl ester, which were detected at 16.19%, 12.53%, and 12.99%, respectively. Based on the mechanisms of action reported for these molecules, Hsf1 could exert its anti-Toxoplasma activity mainly on T. gondii lipidomes and membranes.